Literature DB >> 2514255

Cytotoxic T lymphocyte control of acute lymphocytic choriomeningitis virus infection: interferon gamma, but not tumour necrosis factor alpha, displays antiviral activity in vivo.

L S Klavinskis1, R Geckeler, M B Oldstone.   

Abstract

Virus-specific cytotoxic T lymphocytes (CTL) mediate their antiviral activity either by direct lysis of infected cells, or by the release of soluble lymphokines, or by a combination of the two. We have examined the role played by interferon-gamma (IFN-gamma) and tumour necrosis factor (TNF alpha) in virus clearance. In vitro the amount of IFN-gamma synthesized by some lymphocytic choriomeningitis virus-specific H-2-restricted CTL clones was quantitatively too small to correlate with a direct antiviral activity in vivo. However, treatment of mice with a neutralizing monoclonal antibody to IFN-gamma significantly inhibited the clearance of virus from the spleens of acutely infected mice given adoptive transfers of immune spleen cells. Additionally, mice treated with exogenous recombinant murine IFN-gamma 24 h before or at the same time as virus inoculation showed reduced virus titres in their spleens. Hence, IFN-gamma displayed a direct antiviral effect in vivo. In contrast, treatment of mice with recombinant TNF alpha had no effect on virus clearance and thus TNF alpha is unlikely to play a significant role in this acute viral infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2514255     DOI: 10.1099/0022-1317-70-12-3317

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  29 in total

1.  Role of tumor necrosis factor receptors in regulating CD8 T-cell responses during acute lymphocytic choriomeningitis virus infection.

Authors:  M Suresh; Anju Singh; Christopher Fischer
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Immunodeficient mouse models with different disease profiles by in vivo infection with the same clinical isolate of enterovirus 71.

Authors:  Chun-Che Liao; An-Ting Liou; Ya-Shu Chang; Szu-Yao Wu; Chih-Shin Chang; Chien-Kuo Lee; John T Kung; Pang-Hsien Tu; Ya-Yen Yu; Chi-Yung Lin; Jen-Shiou Lin; Chiaho Shih
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

3.  Modulation by gamma interferon of antiviral cell-mediated immune responses in vivo.

Authors:  O Utermöhlen; A Dangel; A Tárnok; F Lehmann-Grube
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

4.  Vaccination against persistent viral infection exacerbates CD4+ T-cell-mediated immunopathological disease.

Authors:  D Hildeman; D Yañez; K Pederson; T Havighurst; D Muller
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease.

Authors:  S Aung; J A Rutigliano; B S Graham
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Replication of lymphocytic choriomeningitis virus is restricted in terminally differentiated neurons.

Authors:  J C de la Torre; G Rall; C Oldstone; P P Sanna; P Borrow; M B Oldstone
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

7.  Apoptosis induced in mouse hepatitis virus-infected cells by a virus-specific CD8+ cytotoxic T-lymphocyte clone.

Authors:  S Shibata; S Kyuwa; S K Lee; Y Toyoda; N Goto
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

8.  Importance of interferons in recovery from mousepox.

Authors:  G Karupiah; T N Fredrickson; K L Holmes; L H Khairallah; R M Buller
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

9.  Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon.

Authors:  D Moskophidis; M Battegay; M A Bruendler; E Laine; I Gresser; R M Zinkernagel
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  The adenovirus E3 14.7-kilodalton protein which inhibits cytolysis by tumor necrosis factor increases the virulence of vaccinia virus in a murine pneumonia model.

Authors:  J Tufariello; S Cho; M S Horwitz
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.